Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
TVM Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
TVM Capital

TVM Capital

Operating

TVM Capital Life Science is a global venture capital firm specializing in multi-stage investments in life science sectors.

Location
Munich, Bavaria, DE
Founded
1995
Firm
Compare
Portfolio
Employees
Website

TVM Capital Life Science is a global venture capital firm specializing in multi-stage investments within the life science sectors. With offices in Montreal, Canada, and Munich, Germany, the firm focuses on funding companies from the discovery phase to market-ready stages, as well as providing growth capital to profitable enterprises. Their investment rounds typically include Series A, B, C, and D, with investments ranging from early-stage to later-stage companies.

Notable portfolio companies include bluebird bio, which has raised $125 million, Rapid Micro Biosystems with $82.2 million, and Ubidyne with $58.5 million. TVM Capital Life Science is known for its strategic approach to transforming healthcare through funding novel and disruptive innovations. The firm offers significant value-add services, leveraging its extensive expertise to help develop and market breakthrough therapies and medical products that benefit patients and the healthcare system.

TVM Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments31
Current Portfolio Count12
Total Portfolio Exits4

Top Investment Stages

Series B13 (43.3%)
Series C6 (20.0%)
Series A4 (13.3%)
Series Unknown4 (13.3%)
Series D3 (10.0%)

Stage Mix

Series B 43%Series C 20%Series A 13%Series Unknown 13%Series D 10%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Egg Medical logo

Egg Medical

Access Vascular logo

Access Vascular

Rapid Micro Biosystems logo

Rapid Micro Biosystems

bluebird bio logo

bluebird bio

Anchor Therapeutics logo

Anchor Therapeutics

Helomics logo

Helomics

Arteris logo

Arteris

Ubidyne logo

Ubidyne

BitWave Semiconductor logo

BitWave Semiconductor

Ascent Therapeutics logo

Ascent Therapeutics

RenaMed Biologics logo

RenaMed Biologics

Impress Software logo

Impress Software

Amnis logo

Amnis

Interactive Silicon logo

Interactive Silicon

eCustomers.com logo

eCustomers.com

TVM Capital - Similar Investment Firms

TVC Capital logo

TVC Capital

tvccapital.com

TMV logo

TMV

tmv.vc

MVM Partners logo

MVM Partners

mvm.com

Technology Venture Partners US logo

Technology Venture Partners US

tvp.com

TTV Capital logo

TTV Capital

ttvcapital.com

The Venture Collective logo

The Venture Collective

RBV Capital logo

RBV Capital

rbvcapital.com

Global Life Science Ventures logo

Global Life Science Ventures

Bay City Capital logo

Bay City Capital

baycitycapital.com

Vida Ventures logo

Vida Ventures

vidaventures.com

BVM Capital logo

BVM Capital

bvmcap.com

T2M Holding logo

T2M Holding

FTV Capital logo

FTV Capital

ftvcapital.com

Care Capital logo

Care Capital

carecapital.com

Tachyon Ventures logo

Tachyon Ventures

tachyon.vc

TVM Capital - Classification

Also Known As
  • TVM Capital Gmbh.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end